This company has shut down. Frugi Biotechnology is no longer operating — its last tracked round was a Grant in 2021.
Explore the Startup GraveyardFrugi Biotechnology is a synthetic biology company that creates modular, paper-based, secure diagnostics for viral outbreak management.
Frugi Biotechnology has raised $256K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
Frugi Biotechnology's investors include National Science Foundation.
Frugi Biotechnology is headquartered in Ames, United States.
Frugi Biotechnology is a synthetic biology company that creates modular, paper-based, secure diagnostics for viral outbreak management.
Frugi Biotechnology is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Frugi Biotechnology — Funding & Investors." VCBacked, August 1, 2021, https://www.vcbacked.co/company/frugi-biotechnology. Accessed November 14, 2026.
VCBacked. (2021). Frugi Biotechnology — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/frugi-biotechnology
{{cite web |title=Frugi Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/frugi-biotechnology |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Frugi Biotechnology? Request a listing update